BGM Group (BGM) vs Organigram Global (OGI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Organigram Global (OGI) has outperformed BGM Group (BGM) over the past year, losing 51.0% versus a loss of 96.8%. Over five years, OGI leads with a -89.3% price change compared with -98.4% for BGM. Organigram Global is the larger company by market cap ($136.7 million vs $125.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BGM | OGI |
|---|---|---|
| Share price | $9.38 | $0.9482 |
| Market cap | $125.26M | $136.69M |
| 1-day change | -0.11% | -1.23% |
| YTD return | -91.52% | -42.86% |
| 1-year return | -96.77% | -51.02% |
| 5-year return | -98.42% | -89.29% |
| P/E ratio (TTM) | — | 2.21 |
| Forward P/E | — | 39.51 |
| EPS (TTM) | $-4.80 | $0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $303.00 | $2.24 |
| 52-week low | $6.45 | $0.853 |
| Distance from 52-week high | -96.90% | -57.67% |
| Analyst consensus | — | buy |
| Average volume | 6.13K | 882.38K |
| Shares outstanding | 12.69M | 144.15M |
| Employees | — | 1,139 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OGI has outperformed BGM by 45.7 percentage points over the past year.
About BGM Group
BGM stock →BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments.
Health Care · Biotechnology: Pharmaceutical Preparations
About Organigram Global
OGI stock →Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada.
Health Care · Biotechnology: Pharmaceutical Preparations · 1,139 employees
BGM vs OGI FAQ
Which is bigger, BGM Group or Organigram Global?
Organigram Global (OGI) is larger, with a market capitalization of $136.69M compared with $125.26M for BGM Group (BGM).
Which stock has performed better over the past year, BGM or OGI?
OGI returned -51.02% over the past 12 months, compared with -96.77% for BGM (price return, excluding dividends). Past performance does not predict future results.
Are BGM Group and Organigram Global in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.